评论 9
过滤器:
评分
语言
种类:
最近的
J
9 几个月前

I had a wonderful experience with this company. Th...

I had a wonderful experience with this company. The website is informative and easy to use. The customer support team was helpful and resolved my queries promptly. I highly recommend Invivoscribe!

J
11 几个月前

I recently had the pleasure of working with a comp...

I recently had the pleasure of working with a company in the industry. The services and products offered were of great quality and met all my expectations. The website is informative and easy to navigate. Highly recommended!

E
1年以前

👍 Invivoscribe has been an excellent company to wo...

👍 Invivoscribe has been an excellent company to work with. Their dedication to customer satisfaction is commendable. The website is user-friendly and the products are top-notch. I'm really impressed with their service! 👌

L
1年以前

Invivoscribe is a great company to work with. Thei...

Invivoscribe is a great company to work with. Their website is user-friendly and provides all the necessary information. The customer service team is prompt and helpful in answering any queries. Overall, a positive experience!

J
1年以前

I recently had the opportunity to work with Invivo...

I recently had the opportunity to work with Invivoscribe, and I must say, it was a fantastic experience. The website is easy to navigate, and their products are of high quality. I'm really impressed with their overall service. Highly recommended!

N
1年以前

🔥 Invivoscribe is absolutely amazing! Their websit...

🔥 Invivoscribe is absolutely amazing! Their website is user-friendly and provides all the necessary information. The customer support team is extremely helpful. I'm really satisfied with their services. Kudos to the entire team! 👍

关于Invivoscribe

Invivoscribe:20 多年来开创性的诊断产品和试剂

Invivoscribe 是诊断产品和试剂领域的领先公司,在开发创新解决方案以帮助医疗保健专业人员诊断和治疗各种疾病方面拥有超过二十年的经验。由于致力于研究、开发和制造满足全球患者需求的高质量产品,该公司已成为该行业的先驱。

Invivoscribe 由 Jeffrey Miller 博士于 1995 年创立,现已从一家小型初创公司发展成为在北美、欧洲、亚太地区和非洲开展业务的全球领导者。该公司的成功可归因于其专注于提供准确的诊断工具,使临床医生能够就患者护理做出明智的决定。

Invivoscribe 的核心优势之一是其在分子诊断方面的专业知识。该公司开发了多项专有技术,可以高度灵敏地检测与各种癌症和其他疾病相关的基因突变。这些技术包括基于 PCR 的检测,用于检测基因重排,例如与慢性粒细胞白血病 (CML) 相关的 BCR-ABL1 融合转录物或与骨髓增生性肿瘤 (MPN) 相关的 JAK2 V617F 突变。

除了分子诊断,Invivoscribe 还提供基于流式细胞术的检测方法,用于检测正在接受血液系统恶性肿瘤治疗的患者的微小残留病 (MRD),例如急性淋巴细胞白血病 (ALL)、急性髓性白血病 (AML) 或多发性骨髓瘤 (MM) ).这些检测对于监测治疗反应和预测复发风险至关重要。

Invivoscribe 的产品组合包括实验室开发的测试 (LDT) 以及 FDA 批准或 CE 标记的诊断试剂盒。公司与世界各地的学术机构和制药公司密切合作,开发新产品以满足未满足的临床需求。

除了专注于产品开发外,Invivoscribe 还非常重视质量控制和法规遵从性。该公司根据 ISO 13485:2016 认证标准运营,确保从设计到制造的产品开发所有阶段的质量始终如一。

总之,Invivoscribe 是致力于开发创新诊断产品和试剂以改善全球患者治疗效果的行业先驱。凭借基于 PCR 的检测或基于流式细胞术的 MRD 检测系统等尖端技术平台的支持,结合严格的质量控制措施,我们拥有超过 20 年的经验,确保了他们在当今该领域的前沿地位!

已翻译